Medical device companies are dealing with the impact of increasing regulations in a number of ways, including the ...

The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over ...

MSD and Daiichi Sankyo's patritumab deruxtecan hit its main objective in a phase 3 lung cancer study that reinforces its ...

Digital health company Noom has said it intends to launch a compound pharmacy-made version of Novo Nordisk's obesity drug ...

Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the ...

Ioannis Sapountzis, head of global therapeutic areas at Boehringer, said that FIBRONEER-IPF is the largest trial in IPF ...

The critical need to improve prior authorisation processes might have reached its tipping point on the 17th January. That’s ...

As a result, commercial teams are evolving as valuable partners to HCPs. From educating key experts before launch and ...

In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...

Unearthing novel targets for radiopharmaceuticals from ACP3m, AVB6, AVB8, and PDL-1 with Philochem, TRIMT, Fusion-AstraZeneca ...